Advanced Skills in Modern Radiotherapy 2018

Lymph node metastasized prostate cancer

• N=80 • T1-4, N1M0 • Intensity modulated arc radiotherapy (IMAT) + androgen deprivation • Dose: 69,3 Gy in 25 fractions; SIB (intraprostatic lesion): 72 Gy • F/u: 3 years • 3-year late grade 3 GI: 8% • 3-year late grade 3/4 GU: 6% • 3-year bRFS and cRFS was 81% and 89%, respectively.

Radiotherapy and Oncology 109 (2013) 229–234